Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Recent Advances in Polymeric and Lipid Stimuli-Responsive Nanocarriers for Cell-Based Cancer Immunotherapy Publisher Pubmed



A Gharatape ALIREZA ; B Amanzadi BENTOLHODA ; F Mohamadi FARANAK ; M Rafieian MAHDIEH ; R Faridimajidi REZA
Authors

Source: Nanomedicine Published:2024


Abstract

Conventional cancer therapy has major limitations, including non-specificity, unavoidable side effects, low specific tumor accumulation and systemic toxicity. In recent years, more effective and precise treatment methods have been developed, including cell-based immunotherapy. Carriers that can accurately and specifically target cells and equip them to combat cancer cells are particularly important for developing this therapy. As a result, attention has been drawn to smart nanocarriers that can react to specific stimuli. Thus, stimuli-responsive nanocarriers have attracted increasing attention because they can change their physicochemical properties in response to stimulus conditions, such as pH, enzymes, redox agents, hypoxia, light and temperature. This review highlights recent advances in various stimuli-responsive nanocarriers, discussing loading, targeted delivery, cellular uptake, biocompatibility and immunomodulation in cell-based immunotherapy. Finally, future challenges and perspectives regarding the possible clinical translation of nanocarriers are discussed. © 2024 Elsevier B.V., All rights reserved.
Related Docs
View other Related Docs
1. Functionalised Nanomaterials for Eradication of Cscs, a Promising Approach for Overcoming Tumour Heterogeneity, Journal of Drug Targeting (2018)
2. Enzyme and Thermo Dual-Stimuli Responsive Dox Carrier Based on Pnipam Conjugated Mesoporous Silica, Iranian Journal of Pharmaceutical Research (2022)
3. A Concise Review on Cancer Treatment Methods and Delivery Systems, Journal of Drug Delivery Science and Technology (2019)
Experts (# of related papers)
View all Related Experts
Ali Abbasi (1)
Vahid Haghpanah (1)
Other Related Docs
4. Nanovehicles for Co-Delivery of Anticancer Agents, Drug Discovery Today (2020)
5. Redox-Sensitive Smart Nanosystems for Drug and Gene Delivery, Current Organic Chemistry (2016)
6. Nanoimmunoengineering Strategies in Cancer Diagnosis and Therapy, Clinical and Translational Oncology (2023)
7. Smart Mesoporous Silica Nanoparticles in Cancer: Diagnosis, Treatment, Immunogenicity, and Clinical Translation, Small (2025)
8. Application of Nano-Based Systems for Drug Delivery and Targeting: A Review, Journal of Nanoparticle Research (2020)
9. Nanocarrier-Based Gene Delivery for Immune Cell Engineering, Journal of Materials Chemistry B (2024)
10. Temperature-Responsive Smart Nanocarriers for Delivery of Therapeutic Agents: Applications and Recent Advances, ACS Applied Materials and Interfaces (2016)
11. Ph-Sensitive Stimulus-Responsive Nanocarriers for Targeted Delivery of Therapeutic Agents, Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology (2016)
12. Cancer Nanomedicine: Special Focus on Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
13. Recent Advances in Gene Therapy-Based Cancer Monotherapy and Synergistic Bimodal Therapy Using Upconversion Nanoparticles: Structural and Biological Aspects, Biomedicine and Pharmacotherapy (2022)
14. Nanocaged Platforms: Modification, Drug Delivery and Nanotoxicity. Opening Synthetic Cages to Release the Tiger, Nanoscale (2017)
15. Correction To: A Systematic Review of Nano Formulation of Natural Products for the Treatment of Inflammatory Bowel Disease: Drug Delivery and Pharmacological Targets (Daru Journal of Pharmaceutical Sciences, (2018), 26, 2, (229-239), 10.1007/S40199-018-0222-4), DARU# Journal of Pharmaceutical Sciences (2018)
16. Tumor-Associated Macrophages, Nanomedicine and Imaging: The Axis of Success in the Future of Cancer Immunotherapy, Immunotherapy (2017)
17. Controlled Anti-Cancer Drug Release Through Advanced Nano-Drug Delivery Systems: Static and Dynamic Targeting Strategies, Journal of Controlled Release (2020)
18. The Use of Nanoparticles As a Promising Therapeutic Approach in Cancer Immunotherapy, Artificial Cells# Nanomedicine and Biotechnology (2016)
19. Nanoparticles in Cancer Immunotherapies: An Innovative Strategy, Biotechnology Progress (2021)
20. Engineered Hyaluronic Acid-Decorated Niosomal Nanoparticles for Controlled and Targeted Delivery of Epirubicin to Treat Breast Cancer, Materials Today Bio (2022)